{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:21:31Z","timestamp":1783092091043,"version":"3.54.6"},"reference-count":58,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016362","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:55:56Z","timestamp":1783090556000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS)"],"prefix":"10.1002","volume":"2026","author":[{"given":"Allison","family":"Mo","sequence":"additional","affiliation":[{"name":"Transfusion Research Unit, School of Public Health & Preventive Medicine; Monash University; Melbourne Australia"},{"name":"Department of Haematology; Monash Health; Clayton Australia"},{"name":"Austin Health; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Poynton","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology; Oxford University Hospitals NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-9931","authenticated-orcid":false,"given":"Catherine","family":"Kimber","sequence":"additional","affiliation":[{"name":"Systematic Review Initiative; NHS Blood and Transplant; Oxford UK"},{"name":"Nuffield Department of Clinical Laboratory Sciences; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Csenar","sequence":"additional","affiliation":[{"name":"Institute of Public Health, Faculty of Medicine and University Hospital; University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Dor\u00e9e","sequence":"additional","affiliation":[{"name":"Systematic Review Initiative; NHS Blood and Transplant; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Prodger","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology; Oxford University Hospitals NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology; Oxford University Hospitals NHS Foundation Trust; Oxford UK"},{"name":"Radcliffe Department of Medicine; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[{"name":"Transfusion Research Unit, School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD016362-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1365-2141.2003.04272.x","article-title":"Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes","volume":"121","author":"Jansen","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD016362-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/hematology.2020000103","article-title":"Outpatient transfusions for myelodysplastic syndromes","volume":"2020","author":"Wood","year":"2020","journal-title":"Hematology. American Society of Hematology. Education Program"},{"issue":"1","key":"10.1002\/14651858.CD016362-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s41687-020-00235-4","article-title":"Content validity of patient-reported outcomes for use in lower-risk myelodysplastic syndromes","volume":"4","author":"Trudeau","year":"2020","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"4","key":"10.1002\/14651858.CD016362-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer"},{"issue":"14","key":"10.1002\/14651858.CD016362-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1182\/bloodadvances.2022009000","article-title":"Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study","volume":"7","author":"Abel","year":"2023","journal-title":"Blood Advances"},{"issue":"4","key":"10.1002\/14651858.CD016362-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.anpedi.2013.11.028","article-title":"Validity and reliability of the Spanish EQ-5D-Y proxy version","volume":"81","author":"Gusi","year":"2014","journal-title":"Anales de Pediatr\u00eda"},{"issue":"26","key":"10.1002\/14651858.CD016362-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","article-title":"Diagnosis and classification of myelodysplastic syndromes","volume":"142","author":"Hasserjian","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD016362-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.seminhematol.2017.06.003","article-title":"Lenalidomide: myelodysplastic syndromes with del(5q) and beyond","volume":"54","author":"Talati","year":"2017","journal-title":"Seminars in Hematology"},{"issue":"12","key":"10.1002\/14651858.CD016362-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"2454\u20132465","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1002\/14651858.CD016362-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11912-021-01136-5","article-title":"Is myelodysplasia a consequence of normal aging?","volume":"23","author":"Heibl","year":"2021","journal-title":"Current Oncology Reports"},{"issue":"21","key":"10.1002\/14651858.CD016362-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1182\/blood.V116.21.4976.4976","article-title":"Myelodysplastic syndrome patients younger than 50 years: epidemiological data and clinical features","volume":"116","author":"Breccia","year":"2010","journal-title":"Blood"},{"issue":"2-3","key":"10.1002\/14651858.CD016362-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD016362-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2147\/CMAR.S240600","article-title":"Clinical management of anemia in patients with myelodysplastic syndromes: an update on emerging therapeutic options","volume":"13","author":"Lewis","year":"2021","journal-title":"Cancer Management and Research"},{"key":"10.1002\/14651858.CD016362-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.blre.2021.100851","article-title":"Targeting health-related quality of life in patients with myelodysplastic syndromes \u2013 current knowledge and lessons to be learned","volume":"50","author":"Oliva","year":"2021","journal-title":"Blood Reviews"},{"issue":"8","key":"10.1002\/14651858.CD016362-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/17474086.2024.2378035","article-title":"Quality of life considerations in myelodysplastic syndrome: not only fatigue","volume":"17","author":"Niscola","year":"2024","journal-title":"Expert Review of Hematology"},{"issue":"10","key":"10.1002\/14651858.CD016362-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002042.pub6","article-title":"Transfusion thresholds and other strategies for guiding red blood cell transfusion","author":"Carson","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD016362-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/trf.17540","article-title":"An analysis of quality of life and functional outcomes as reported in randomized trials for red cell transfusions","volume":"63","author":"Pagano","year":"2023","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD016362-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.blre.2023.101114","article-title":"Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review","volume":"61","author":"Mo","year":"2023","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD016362-BIB0019|cit19","unstructured":"Summary and findings from Cochrane Haematology\u2019s Priority Setting Process https:\/\/haematology.cochrane.org\/scope-our-work\/priority-setting-exercise\/summary-and-findings-cochrane-haematologys-priority"},{"key":"10.1002\/14651858.CD016362-BIB0020|cit20","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD016362-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016362-BIB0022|cit22","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD016362-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013092.pub2","article-title":"Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews","author":"Da Silva Lopes","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD016362-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/ejhf.514","article-title":"Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review","volume":"18","author":"Clevenger","year":"2016","journal-title":"European Journal of Heart Failure"},{"issue":"Suppl. 3","key":"10.1002\/14651858.CD016362-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD016362-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/bjh.16654","article-title":"Development of a core outcome set for myelodysplastic syndromes \u2013 a Delphi study from the EUMDS Registry Group","volume":"191","author":"Rochau","year":"2020","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD016362-BIB0027|cit27","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD016362-BIB0028|cit28","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2025"},{"issue":"2","key":"10.1002\/14651858.CD016362-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD016362-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood-2018-06-857102","article-title":"Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials","volume":"133","author":"Platzbecker","year":"2018","journal-title":"Blood"},{"issue":"3 Suppl 2","key":"10.1002\/14651858.CD016362-BIB0031|cit31","first-page":"13","article-title":"The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue","volume":"34","author":"Cella","year":"1997","journal-title":"Seminars in Haematology"},{"issue":"5","key":"10.1002\/14651858.CD016362-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD016362-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/jco.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD016362-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0895-4356(98)00081-x","article-title":"Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project","volume":"51","author":"Ware","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD016362-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD016362-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1507854","DOI":"10.3389\/fonc.2025.1507854","article-title":"Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms","volume":"15","author":"Oliva","year":"2025","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"10.1002\/14651858.CD016362-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1182\/blood-2013-11-540021","article-title":"Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life","volume":"123","author":"Abel","year":"2014","journal-title":"Blood"},{"key":"10.1002\/14651858.CD016362-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD016362-BIB0039|cit39","unstructured":"World Health Organization WHO Handbook for Reporting Results of Cancer Treatment WHO Offset publication 1979 48"},{"key":"10.1002\/14651858.CD016362-BIB0040|cit40","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (chapter last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0041|cit41","unstructured":"Cumpston M Lasserson T Flemyng E Page MJ Chapter III: Reporting the review (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0042|cit42","unstructured":"Covidence Veritas Health Innovation 2026"},{"key":"10.1002\/14651858.CD016362-BIB0043|cit43","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0044|cit44","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Chapter 9: Summarizing study characteristics and preparing for synthesis (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016362-BIB0046|cit46","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies (chapter last updated August 2022). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0047|cit47","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0048|cit48","unstructured":"Thomas J Kneale D McKenzie JE Brennan SE Bhaumik S Chapter 2: Determining the scope of the review and the questions it will address (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0049|cit49","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"7109","key":"10.1002\/14651858.CD016362-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD016362-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/1536867X080080020","article-title":"Contour-enhanced funnel plots for meta-analysis","volume":"8","author":"Palmer","year":"2008","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD016362-BIB0052|cit52","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0053|cit53","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0054|cit54","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD016362-BIB0055|cit55","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0056|cit56","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016362-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016362-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:56:33Z","timestamp":1783090593000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016362"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016362","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}